Priority setting for the implementation of artemisinin-based combination therapy policy in Tanzania: evaluation against the accountability for reasonableness framework
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1748-5908
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Priority setting for the implementation of artemisinin-based combination therapy policy in Tanzania: evaluation against the accountability for reasonableness framework ; volume:7 ; number:1 ; day:18 ; month:3 ; year:2012 ; pages:1-8 ; date:12.2012
Implementation science ; 7, Heft 1 (18.3.2012), 1-8, 12.2012
- Creator
-
Mori, Amani Thomas
- Contributor
-
Kaale, Eliangiringa Amos
SpringerLink (Online service)
- DOI
-
10.1186/1748-5908-7-18
- URN
-
urn:nbn:de:1111-2016070921607
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mori, Amani Thomas
- Kaale, Eliangiringa Amos
- SpringerLink (Online service)
Other Objects (12)
Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon
Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia
Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies
Brazilian Plasmodium falciparum isolates: investigation of candidate polymorphisms for artemisinin resistance before introduction of artemisinin-based combination therapy
Preference for Artemisinin–based combination therapy among healthcare providers, Lokoja, North-Central Nigeria
Willingness and ability to pay for artemisinin-based combination therapy in rural Tanzania
Strategies for deploying triple artemisinin-based combination therapy in the Greater Mekong Subregion
Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania
From chloroquine to artemisinin-based combination therapy: the Sudanese experience
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
Stabilizing supply of artemisinin and artemisinin-based combination therapy in an era of wide-spread scale-up
Deploying triple artemisinin-based combination therapy (TACT) for malaria treatment in Africa: ethical and practical considerations
Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon
Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia
Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies
Brazilian Plasmodium falciparum isolates: investigation of candidate polymorphisms for artemisinin resistance before introduction of artemisinin-based combination therapy
Preference for Artemisinin–based combination therapy among healthcare providers, Lokoja, North-Central Nigeria
Willingness and ability to pay for artemisinin-based combination therapy in rural Tanzania
Strategies for deploying triple artemisinin-based combination therapy in the Greater Mekong Subregion
Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania
From chloroquine to artemisinin-based combination therapy: the Sudanese experience
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
Stabilizing supply of artemisinin and artemisinin-based combination therapy in an era of wide-spread scale-up
Deploying triple artemisinin-based combination therapy (TACT) for malaria treatment in Africa: ethical and practical considerations
Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon
Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia
Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies
Brazilian Plasmodium falciparum isolates: investigation of candidate polymorphisms for artemisinin resistance before introduction of artemisinin-based combination therapy
Preference for Artemisinin–based combination therapy among healthcare providers, Lokoja, North-Central Nigeria
Willingness and ability to pay for artemisinin-based combination therapy in rural Tanzania
Strategies for deploying triple artemisinin-based combination therapy in the Greater Mekong Subregion
Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania
From chloroquine to artemisinin-based combination therapy: the Sudanese experience
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
Stabilizing supply of artemisinin and artemisinin-based combination therapy in an era of wide-spread scale-up